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ABSTRACT
The Memory Complaints Inventory (MCI) is a self-report questionnaire developed by
Paul Green to provide further effort-related evidence in neuropsychiatric practice. It is
comprised of nine subscale scores, in addition to the imbedded Plausible and Implausible
symptom validity scales. The current study utilized archival MCI scores in dementia
populations to determine the presence of, and difference between, genuine memory
impairment profiles in separate subgroups of cognitive impairment. The study sample
consisted of 244 adults presenting to an outpatient neuropsychology practice for
evaluation of memory impairment. The diagnostic categories of the sample consisted of
Alzheimer’s Disease (n = 21), Vascular Dementia (n = 33), Mild Cognitive Impairment
(n = 53), Pseudodementia (n = 88), and Poor Effort (n = 49). Results indicated significant
differences in all twelve one-way ANOVAs to represent differences between subgroups
on each memory-related subscale of the MCI, the overall MCI score, and the imbedded
Plausible and Implausible validity scales. Post-hoc analyses revealed large differences
between the dementia categories and the Poor Effort subgroup, providing further
evidence for the use of the MCI as a symptom validity measure due to its ability to
differentiate between poor effort and genuine neurological impairment. Further support
of the study’s findings would result in reliable genuine memory impairment profiles to
provide further diagnostic and prognostic specificity in general medical practice settings.
KEYWORDS: Memory Complaints Inventory (MCI), Dementia, Alzheimer’s Disease,
Vascular Dementia, Mild Cognitive Impairment, Pseudodementia, Poor Effort, validity
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INTRODUCTION

Memory complaints are an inevitable part of neuropsychiatric practice. The
validity of subjective memory complaints, however, has been widely disputed, as many
reported memory complaints do not resemble the resulting diagnosis. Some individuals
will claim severe difficulty in daily memory tasks, yet receive a diagnosis of mild
cognitive impairment, while others report few, if any, memory difficulties, yet a
diagnosis of dementia, Alzheimer’s type is warranted. Graham, Emery, and Hodges
(2004) suggest distinctive cognitive profiles among unique dementia populations, which
facilitate more effective diagnoses. For example, the inability to recognize specific
deficits that are evident to clinicians or caregivers (anosognosia) has been widely
prevalent in Alzheimer’s patients, however, the frequency of individuals with
anosognosia in mild cognitive impairment is nearly absent (Orfei et al., 2010). Further,
cognitive performance should be considered in differing neuropsychiatric profiles, as
executive deficits are more prominent in individuals with subcortical ischaemic vascular
disease, and episodic memory deficits are more prominent in individuals with
Alzheimer’s Disease (Graham, Emery, & Hodges, 2004; Jokinen et al., 2006). Clearly,
differing diagnostic categories suggest divergent neuropsychiatric profiles, as well as
divergent subjective memory complaints.
Given each subgroup of dementia produces a unique neurocognitive profile,
subjective memory complaints may not be an accurate depiction of an individual’s
specific diagnosis. One study found subjective memory complaints displayed an
uncertain relationship with objective memory performance, creating a heightened rate of
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false positive and false negative diagnoses (Lenehan, Klekociuk, & Summers, 2012). In
a study by Thompson, Henry, Rendell, Withall, and Brodaty (2015), a self-report and an
informant-report of prospective memory difficulties were given to family members and
individuals with dementia or mild cognitive impairment, and results indicated that neither
self-report nor informant-report accurately measured prospective memory impairments.
However, many studies have found subjective memory complaints highly correlated with
the prediction of the onset of dementia (Luck et al., 2015; Mitchell, Beaumont, Ferguson,
Yadegarfar, & Stubbs, 2014; Waldorff, Siersma, Vogel, & Waldemar, 2012). Although
subjective memory complaints are idiosyncratic and inconsistent with current cognitive
impairment, much of the literature suggests that the perceived memory impairments
continue to have high predictive validity of diagnostic outcome (L. M. Reid &
Maclullich, 2006).
Though subjective memory complaints have been studied extensively among
dementia subgroups, relatively little research has been directed towards examining a
normative-group model of measuring subjective memory complaints among these
populations. For example, the Memory Complaint Questionnaire (MAC-Q) is a brief
measure of subjective memory complaints in individuals with “normal” cognitive
functioning, but it is greatly influenced by affective states (M. Reid et al., 2012). The
Subjective Memory Complaints Questionnaire (SMCQ) consists of subjective memory
complaints for general and every day memory, however, Duman, Ozel-Kizil, Baran,
Kirici, and Turan (2011) found that the SMCQ tends to correlate with depressive
symptoms (Youn et al., 2009). The Memory Complaint Scale (MCS) differentiates
demented elderly adults from normal elderly adults by identifying types of memory
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complaints, however, more research is needed to replicate the findings (Vale, Balieiro, &
Silva-Filho, 2012). Amid the multitude of questionnaires created to assess subjective
memory complaints, there are virtually no normative comparison samples of clinical
memory disorders for objective evaluation of the subjective memory complaints. This
lack of data creates inconsistency in the weight of responses to subjective memory
questions, as well as difficulty in differentiating those with true memory impairment and
those who are malingering or those with true psychological distress, rather than
neurocognitive distress. Specifically, those who exaggerate memory complaints in the
self-reported memory questionnaires often perform poorly for external gain, presenting
themselves in a negative manner, rather than due to genuine neurological impairment. For
example, some individuals may exaggerate their memory impairment as a method of
obtaining disability. Further, detection of malingering or determining specificity of
diagnostic categories of dementia is largely impossible during the rapid and brief
assessment conducted in a general medical practice due to the use of short general
measures of cognitive functioning, such as the Mini Mental Status Exam (MMSE), the
Saint Louis University Mental Status (SLUMS) exam, and the Montreal Cognitive
Assessment (MOCA), in addition to subjective self-report. A specific assessment that
encompasses validity subscales and an overall measure of memory impairment may be
useful for general medical practice as informative of treatment planning and prognosis
indicators for both the patient and family members or loved ones.
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Memory Complaints Inventory
The Memory Complaints Inventory (MCI) is a standardized self-report measure
of subjective memory complaints that simultaneously functions as a symptom validity
test (SVT), developed by Green (2004). The MCI consists of 58 items, divided into nine
separate categories. These categories include: General Memory Problems (GMP),
Numerical Information Processing and Memory Problems (NIP), Visual-Spatial Memory
Problems (VSMP), Verbal Memory Problems (VMP), Pain Interferes with Memory
(PIM), Memory Interferes with Work (MIW), Impairment of Remote Memory (IRM),
Amnesia for Complex Behavior (ACB), and Amnesia for Antisocial Behavior (Green,
2004). The MCI also contains Plausible and Implausible scales which inherently
establishes a symptom validity test by portraying elevations on the Implausible scale
when patients answer questions related to poor effort in a way that would not be
consistent with genuine impairment, even in severe traumatic brain injury populations
(Green, 2004). Therefore, if an individual scores high on the MCI overall, as well as the
Implausible scales, it is likely that he or she may be exaggerating their memory
impairment. The MCI has high reliability ( = 0.93) for all nine scales, as well as high
internal reliability, assessed by split-thirds reliability standards (Green, 2004).
The MCI is administered via computer and presents two non-memory related
questions for practice about eating fresh vegetables and drinking tea or coffee. The
individual is asked to rate how well the statement describes their experience within the
last month. The MCI consists of a Likert Rating Scale style which ranges from 0 to 4 (0 =
not at all true, 1 = a little true, 2 = moderately true, 3 = quite a bit true, 4 = extremely
true). After the results are obtained, the program will generate a report based on
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comparisons used in the sample population which was used to construct the MCI and
there is an option to observe the patients’ scores with the best fit comparison group.
The MCI was originally created as a symptom validity test to facilitate clinicians
in identifying symptom exaggeration by means of self-report and to correlate with the
Minnesota Multiphasic Personality Inventory – Second Edition – Restructured Form
(MMPI-2-RF) scales of validity (Green, 2004). The MCI then provides evidence of
symptom exaggeration in self-reports in neuropsychological settings. Paul Green’s
previous assessment instruments have primarily encompassed performance validity tests
(PVTs), which rely on an individual’s performance compared to a normative sample, to
assess symptom exaggeration in patients’ functioning, rather than patients’ self-report of
their current functioning. Therefore, the MCI, as a self-report measure of symptom
validity correlates highly with performance on PVTs (Armistead-Jehle, Gervais, &
Green, 2012b).
Previous research with the MCI has mainly focused on performance validity test
presentation only, as well as disability-assessment in clinical practice. A study by
Armistead-Jehle et al. (2012b) assessing individuals seeking disability status found as
scores on performance validity tests (PVTs) decreased, scores on the MCI, a symptom
validity test (SVT) increased. The authors also found non-significant correlations
between self-reported memory impairments and objective measures of memory
performance in a disability seeking sample (Armistead-Jehle et al., 2012b). These
findings indicate how a possible gain from a psychological evaluation can pose as a
harmful factor on the efficacy of subjective memory complaints in neuropsychological
practice, as scores reflect inflated symptomology as opposed to true levels of memory
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impairment (Armistead-Jehle et al., 2012b). As a result of those findings, ArmisteadJehle, Gervais, and Green (2012a) conducted a study investigating PVTs in a clinical
sample that appeared absent of external gain. Their results indicated similar findings as
the previous study supporting the inverse relationship between MCI scores and PVT
scores, however, the Amnesia for Complex Behavior (ACB) and Amnesia for Antisocial
Behavior (AAB) scales were not as strongly correlated with PVT scores as the previous
study suggested (Armistead-Jehle et al., 2012a). The ACB and AAB scales are built into
the MCI to determine Implausible memory complaints, and ACB and AAB are not
typically elevated, even in neurologically impaired populations. The results indicated
these select scales (ACB and AAB) may not discriminate between those who appeared to
have external gain and those who appeared without external gain (Armistead-Jehle et al.,
2012a).
Furthermore, Armistead-Jehle, Grills, Bieu, and Kulas (2016) conducted a study
to evaluate the MCI to determine classification statistics in relation to the Medical
Symptom Validity Test (MSVT), the Non-Verbal Medical Symptom Validity Test (NVMSVT), the Personality Assessment Inventory (PAI), and the Minnesota Multiphasic
Personality Inventory-II-Restructured Form (MMPI-2-RF). Their results found that
individuals displayed elevated MCI scores on all scales when they failed the MSVT and
the NV-MSVT, as well as when individuals elevated validity scales on the PAI and the
MMPI-2-RF (Armistead-Jehle et al., 2016). These findings support the use of the MCI as
a self-report measure of symptomology by showing high classification statistics in
relation to SVTs and Performance Validity Tests (PVTs) (Armistead-Jehle et al., 2016).
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Consistent with previous research, the current study focused on MCI profiles in a
clinical sample of patients presenting to a neuropsychological practice for reported
memory impairment. The researchers postulated that the MCI scale profiles would
therefore be consistent with the cognitive profile of the dementia subgroups. As a result,
the reported memory difficulties of the sample is predicted to have an inverse relationship
with the severity of the disorder. In terms of severity of memory impairment, the current
study focused on four subgroups of dementia, comprised of Alzheimer’s Disease,
Vascular Dementia, Mild Cognitive Impairment, and Pseudodementia, as well as a group
classified with Poor Effort to further explore the MCI as a symptom validity test.

Alzheimer’s Disease
Alzheimer’s Disease is a well-known diagnosis in our contemporary medical and
social terminology. The Alzheimer’s Foundation of America (2016) estimates that as
many as 5.1 million Americans may currently meet criteria for an Alzheimer’s Disease
diagnosis, and the incidence of the disease is rising as the population is living longer.
Currently, 1.5% of the population is affected, however, as our older population continues
to increase, estimates suggest that 20% of Americans will be affected by the disorder by
the year 2050 (Alzheimers Foundation of America, 2016). The prevalence of the disorder
has produced an abundance of research on the topic, creating the development of a
typical neurocognitive profile of an individual diagnosed with Alzheimer’s Disease. A
diagnosis of Alzheimer’s Disease subsumes a number of factors related to the disorder,
including significant cognitive deficits, anosognosia, impaired activities of daily living
(ADL), and a newfound necessity of a caretaker.
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The American Psychiatric Association (2013) defines an Alzheimer’s Disease
diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM5) as having an insidious onset and gradual progression of impairment in one or more
cognitive domains, with evidence of a causative Alzheimer’s disease genetic mutation
(obtained by genetic testing or family history), evidence of memory and learning decline,
accompanied by decline in at least one other cognitive domain, progressive and gradual
decline in cognition, and no evidence of mixed etiology (American Psychiatric
Association, 2013). Cognitive domains affected by the progression of Alzheimer’s
Disease can include memory, language, attention, executive functioning, and visuospatial
functioning (Caccappolo-Van Vliet et al., 2003). Research by Smits et al. (2015) posited
that individuals diagnosed with Alzheimer’s Disease demonstrated decline in all
cognitive domains after a 1.5-year follow-up, with memory displaying the most
impairment in comparison with other dementia subgroups.
In addition to cognitive deficits produced by Alzheimer’s Disease, anosognosia is
a primary factor related to the disorder. Anosognosia exists among a continuum and is
not domain specific. A review of the literature suggests a positive correlation between
anosognosia and the progression of cognitive decline (Clare, Wilson, Carter, Roth, &
Hodges, 2004; Ecklund-Johnson & Torres, 2005; Lehrner et al., 2015). Further,
anosognosia is associated with higher age, a decreased number of depressive symptoms,
and self-reported functional impairment (Lehrner et al., 2015). Impaired insight was
equally represented in a comparison of amnesic mild cognitive impairment and mild
Alzheimer’s Disease patients (Vogel et al., 2004). These results advance the Lehrner et
al. (2015) findings, as it can be assumed that the progression from amnesic mild cognitive
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impairment comes slightly before a diagnosis of mild Alzheimer’s Disease, meaning that
the two groups should be relatively similar in anosognosia symptomology.
Much like anosognosia and cognitive functioning, functional impairment or
impairment in independent activities of daily living (IADL) exists on a non-domain
specific continuum, and has been found to increase with the progression of Alzheimer’s
Disease (Galasko et al., 2005). A number of factors are thought to contribute to and
affect ADLs, including executive function deficits, depression, and fine motor abilities.
Executive functions, according to Barry (2012), are a set of cognitive abilities that
regulate other abilities, such as goal-directed behavior, planning future behavior,
anticipating outcomes, adapting to situations, forming concepts, and thinking abstractly.
A correlational meta-analysis posits that executive functioning is associated with
functional abilities, while also suggesting that an increase in age and Mini Mental Status
Exam (MMSE) scores with significant executive dysfunction may result in higher
functional impairment than executive dysfunction alone (Martyr & Clare, 2012). Tekin,
Fairbanks, O’Connor, Rosenberg, and Cummings (2001) support the previous findings of
the correlation between executive dysfunction and impaired IADLs, however, the results
of their study maintained that functional impairment resulting from executive dysfunction
and/or psychiatric symptoms may be mediated by frontal lobe dysfunction which is
inherent in all Alzheimer’s Disease patients. While many studies have found an
association between depression and functional impairment in individuals with
Alzheimer’s Disease (Payne et al., 1998; Starkstein, Jorge, Mizrahi, & Robinson, 2005),
Tekin et al. (2001) did not support a relationship between the two constructs. However,
the authors found strong correlations between psychosis, agitation, anxiety, apathy, and
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aberrant motor behavior, and explain their lack of an association due to their
measurement of the apathy construct (Tekin et al., 2001). Finally, research indicates that
impairment in fine motor abilities increases with the progression of the disease which
causes a decrease the IADLs, reducing independent self-care (de Paula et al., 2016). This
increase in impairment in IADLs is the root of the necessity for a care-giver with the
progression of Alzheimer’s Disease.

Vascular Dementia
Vascular dementia accounts for approximately 15% of all dementia cases, and is
the second-most diagnosed subgroup of dementia, surpassed by Alzheimer’s Disease
(O’Brien & Thomas, 2015). Historically, uncertainties about the classification and
diagnostic criteria for Vascular dementia have made this subgroup of dementia widely
misunderstood. Vascular dementia is a condition in which a cerebrovascular event
transpires, leaving behind varying levels of cognitive impairment. Because the diagnosis
itself has the word “dementia” in its title, individuals often believe that memory
impairment is a prominent feature of the disorder. However, O’Brien and Thomas (2015)
posit that vascular dementia’s effect on memory varies to differing degrees and fails to
follow the progressive pattern of Alzheimer’s, therefore, suggest the term ‘vascular
cognitive impairment’ may encompass a more appropriate depiction of this specific
condition. For the purpose of this paper, the terms will be used interchangeably. Vascular
Dementia can develop due to a variety of differing vascular complications, including
multiple cortical infarcts, lacunes, extensive white matter lesions, demyelination, gliosis,
haemorrhagic changes, and amyloid angiopathy (O’Brien & Thomas, 2015). Because of
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the variations of vascular events that occur, Vascular Dementia involves many avenues in
which a diagnosis is warranted, thus creating a large accumulation of research on the
matter, and an inconsistent neurocognitive profile. However, a diagnosis of Vascular
Dementia can typically assume significant cognitive changes and certain neuropsychiatric
features.
To warrant a diagnosis of Vascular Dementia using criteria from the Diagnostic
and Statistical Manual of Mental Disorders (DSM-5), an individual would need to display
evidence of a significant cognitive decline in one or more cognitive domains, the deficits
would need to interfere with independence in ADLs, the features would need to be
consistent with a vascular etiology, there would need to be evidence of the presence of
cerebrovascular disease, and the symptoms should not be explainable by another medical,
mental, or brain disease/disorder (American Psychiatric Association, 2013). The
American Psychiatric Association (2013) suggests that cognitive domains affected by
neurocognitive impairment may include complex attention, executive function, learning
and memory, language, perceptual motor, and social cognition. Evidence of vascular
etiology is to be determined by either temporal relation to a cerebrovascular event or a
decline in complex attention and frontal-executive functioning. Finally, presence of
cerebrovascular disease is discovered through an individual’s history, a physical
examination, and/or a form of neuroimaging to explain neurocognitive deficits (American
Psychiatric Association, 2013). Because of the varying vascular events that may result in
a diagnosis of Vascular Dementia, there are an array of vascular neurocognitive profiles.
This study focused on individuals who have a “typical” vascular neurocognitive profile,
according to Levy and Chelune (2007), consisting of executive functioning deficits,
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learning and memory issues, and prominent depressed mood to encompass most
variations of Vascular Cognitive Impairment.
A review of the literature posits deficits in executive functioning as one of the
largest markers for a vascular neurocognitive profile (Graham et al., 2004; Jokinen et al.,
2006; Kandiah, Narasimhalu, Lee, & Chen, 2009; Levy & Chelune, 2007; Traykov et al.,
2004). Jokinen et al. (2006) purported that executive deficits, incorporating mental
flexibility, set shifting, response inhibition, and fluency are prominent characteristics of
subcortical ischemic vascular dementia. Another study found that individuals with
Vascular Dementia had a greater number of perseverations on an assessment that
measures “stuck-in-set perseverations,” suggesting vascular etiologies result in greater
difficulty with switching tasks and thought processes (Traykov et al., 2004). This
presumes those affected by vascular etiology have difficulty in shifting attention toward
new stimuli because they are fixated on previous and/or possibly absent stimuli.
Naturally, this would create functional deficits in IADLs, as well as deficits in social and
interpersonal interaction. Levy and Chelune (2007) suggest executive deficits as a result
of the disruption of the frontal-subcortical circuits. The area of the brain affected by
vascular etiology will greatly influence the way in which executive deficits occur in
different individuals.
In addition to executive dysfunction, individuals with Vascular Dementia or
Vascular Cognitive Impairment also suffer from a spectrum of memory problems.
Compared with Alzheimer’s Disease, episodic memory tends to be more intact for
individuals diagnosed with Vascular Dementia (O'Brien et al., 2003). However, memory
difficulties associated with Vascular Dementia often include poor performance on
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procedural memory tasks and poor ability to maintain learning for future tasks (Levy &
Chelune, 2007). Graham et al. (2004) also found individuals diagnosed with Vascular
Dementia show greater deficits in semantic memory. These findings suggest individuals
with Vascular Cognitive Impairment struggle with memory complications much like
Alzheimer’s Disease patients; however, Vascular Cognitive Impairment typically
manifests memory complications in relation to the location of the vascular etiology,
producing several manifestations of memory impairment. Unfortunately, research
findings have also indicated individuals with Vascular Dementia suffer from anosognosia
related to their memory functioning, although the severity is less than those affected by
Alzheimer’s Disease (Morris et al., 2016). As a result, memory impairment in Vascular
Dementia seems to be deviant from that of Alzheimer’s Disease, but both types of
impairments effect every-day functioning and estimation of abilities.
To further complicate the neurocognitive profile of Vascular Dementia/Vascular
Cognitive Impairment, patients diagnosed with the disorder often suffer from mood
related difficulties, as well, thus creating complications differentiating pure depressive
symptomology from objective neurodegenerative concerns or most commonly a
combination of the two. Park et al. (2007) conducted a study in which various patients
with subtypes of dementia were matched on gender and dementia severity, and then
compared the rates of depression within the groups. As a result, depressive symptoms
were common in both Vascular Dementia patients, as well as Alzheimer’s Disease
patients; however, the patients with Vascular Dementia suffered from more depressive
symptoms more often than that of Alzheimer’s Disease patients (Park et al., 2007).
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Mild Cognitive Impairment
Mild Cognitive Impairment is a construct which reflects abnormal cognitive
performance for one’s age and accounts for 3% to 19% of the population over the age of
65 (Gauthier et al., 2006). More specifically, the diagnostic criteria for Mild Cognitive
Impairment consists of the following: (1) subjective memory complaint, (2) preserved
activities of daily living, (3) intact general cognitive function, (4) memory impairment
exceeding what would be expected for the normal aging process, and (5) no dementia
diagnosis (Petersen et al., 1999). Subsequently, Petersen (2003), formulated three
subtypes of Mild Cognitive Impairment, consisting of amnestic, multiple domain, and a
single non-memory domain. The amnestic form of Mild Cognitive Impairment is the
most common form of the diagnosis and likely results in a diagnosis of Alzheimer’s
disease after disease progression has occurred, and involves mainly significant memory
impairment with no impairment in other cognitive domains (Petersen, 2003). The
multiple domain form of Mild Cognitive Impairment typically encompasses minor
impairments in activities of daily living and other general cognitive domains, such as
executive function and language (Petersen, 2003). Further, single, non-memory domain
Mild Cognitive Impairment is as the name implies, consisting of impairment in a single
cognitive domain (e.g., executive functioning, language, visuospatial processing) without
impairment in memory functioning (Petersen, 2003). Although the subtypes are important
for diagnostic and clinical implications, the current study engenders all subtypes of Mild
Cognitive Impairment without subtype specification to encompass Mild Cognitive
Impairment in relation to a subjective memory complaints profile.
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Mild Cognitive Impairment may be comprised of different etiologies, consisting
of either degenerative, vascular, psychiatric, or traumatic etiologies (Petersen, 2004).
Thus, differing etiologies may result in differences in projected outcome or progression
of Mild Cognitive Impairment and variations of subjective memory complaint or
activities of daily living. A diagnosis of Mild Cognitive Impairment is likely to lead to
the eventual diagnosis of dementia with the progression of the aging process, specifically,
the diagnosis of amnestic Mild Cognitive Impairment results in the greatest association
with transition to Alzheimer’s Disease (Busse, Hensel, Guhune, Angermeyer, & RiedelHeller, 2006). Due to the high association between Mild Cognitive Impairment and later
dementia, clarity and accuracy of the diagnosis is pertinent to the treatment
recommendations and clinical implications of the patient’s life going forward,
accordingly, accurate profile mapping is necessary for this domain.
To further complicate assessment and diagnosis of Mild Cognitive Impairment, it
is often accompanied by comorbid depression, meaning it is critical to distinguish
cognitive impairment or decline from typical cognitive insufficiencies produced by
depression alone or if there are comorbid diagnoses occurring (Ravdin & Katzen, 2013).
Panza et al. (2009) posit 34% of patients diagnosed with MCI have co-occurring
depressive symptomology. Of note, the patients in this study may not have met diagnostic
criteria for Major Depressive Disorder; however, the patients were experiencing
clinically significant depressive symptomology. If comorbidities occur, it is possible an
evaluator may interpret memory performance more critically than those who have a
single diagnosis of Mild Cognitive Impairment or depression. As addressed previously,
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the diagnostic implications for Mild Cognitive Impairment alone differ greatly than the
diagnostic implications for depression alone or the comorbidity of the two diagnoses.

Pseudodementia
Pseudodementia is a term that signifies cognitive deficits due to the effects of
depressive symptomology, in the absence of organic dementia. Therefore,
Pseudodementia, as a term, can be utilized interchangeably with Depression-Related
Cognitive Impairment, which is a more preferred term in clinical practice. Ravdin and
Katzen (2013) posit depression in older adults living in in a community-dwelling
population has a prevalence rate of approximately 3 to 14 percent; over the course of one
year, 1 in 15 older adults may experience major depression. In this case, the cognitive
decline or deficits experienced are purely caused by psychiatric illness, rather than
dementia-related illness. Unfortunately, experiencing late-life depression increases the
risk of later developing dementia (Ravdin & Katzen, 2013).
The presentation of Pseudodementia has been found to produce significant
cognitive complaints, often accruing more subjective complaints than those diagnosed
with dementia (Siu, 1991). Further, Siu (1991) posits the reported cognitive complaints
are often out of proportion to the level of the individual’s current functioning capabilities,
producing a profile of catastrophizing thought-related symptomology. This would present
as a patient reporting severe memory impairment, yet consistently engaging in everyday
activities such as managing finances, driving independently, cooking independently,
and/or managing medications for oneself or someone else. This is in opposition with
those independently diagnosed with Alzheimer’s Dementia or later stages of Vascular
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Dementia in which anosognosia impairs the patient’s insight into their current capabilities
of independent functioning, producing fewer subjective complaints of memory
impairment.
Further, prominent features of Pseudodementia are shared with that of Major
Depression and may be difficult to differentiate from early features of distinctive types of
dementia. For example, research suggests apathy is a prominent early feature of
Alzheimer’s Disease and is also known to be a pronounced feature of depression;
however, there is a discrimination between apathetic syndrome in Alzheimer’s Disease
and dysphoric mood in depression, thus creating a need for accurate assessment and
careful dissection of hardly distinguishable symptomology (Hattori, Yoshiyama, Miura,
& Fujie, 2010; Landes, Sperry, Strauss, & Geldmacher, 2001). Therefore, at face value,
the two symptoms may be inseparable, but additional investigation is necessary to
illuminate primary features of depression versus an early marker of preclinical
Alzheimer’s Disease. As a result, the prevalence, risk factors, and clinical presentation
associated with late-life depression advance the need for clarity in subjective memory
complaints in patients presenting to outpatient treatment clinics for medical necessity or
psychiatric necessity.

Poor Effort
Poor effort or malingering (or feigning; all terms are used interchangeably) can be
defined as the intentional exaggeration of neurological and/or psychological symptoms
for the gain of an identifiable external reward (American Psychiatric Association, 1994).
With the advancement of the field of neuropsychology and forensic neuropsychology,
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specifically, there has been an uptick of individuals presenting in outpatient assessment
settings for the purpose of personal injury litigation, worker’s compensation, and other
situations in which patients may gain financially from neuropsychiatric diagnoses (Slick,
Sherman, & Iverson, 2010). Thus, the development of validity assessment was necessary
to facilitate identification of feigned symptomology versus genuine neurologically
impaired symptomology in these specific cases.
With the need of validity assessment came the abundance of scales and tasks
developed to highlight feigning. A list of these tasks include the Test of Memory
Malingering (TOMM), the Structured Inventory of Malingered Symptomology (SIMS),
the Medical Symptom Validity Test (MSVT), the Non-Verbal Medical Symptom
Validity Test (NV-MSVT), the Word Memory Test (WMT), and the Memory Complaints
Inventory (MCI) which is utilized in the current study. This list is not an exhaustive
account of all measures available for validity assessment; however, it is to provide insight
into the multiple ways in which practitioners are capable of assessing malingering in both
performance and symptom report measures. Therefore, with the variety of measures to
choose from, the question bodes how neuropsychologists are able to categorize patients
into the Poor Effort subgroup in their practice.
Diagnostic criteria for poor effort proposed by Slick et al. (2010) highlights three
diagnoses of malingering to differentiate: Definite Malingering Neurocognitive
Dysfunction, Probable Malingering Neurocognitive Dysfunction, and Possible
Malingering Neurocognitive Dysfunction. All three diagnoses of malingering consist of
four components which must be met for poor effort or malingering to be considered: (1)
presence of a substantial external incentive, (2) evidence from neuropsychological
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testing, (3) evidence from self-report, and (4) behaviors meeting necessary criteria are not
accounted for by psychological, neurological, or developmental conditions (Slick et al.,
2010). In order to specify and rule out uncertainty within these criteria, the authors
proposed that the evidence of neuropsychological testing can be comprised of a negative
response bias, probable response bias, or a discrepancy between test data and brain
functioning, observed behavior, collateral reports, or documented background history
(Slick et al., 2010). Similarly, the authors detailed that evidence from self-report needs to
encompass a discrepancy between self-reported history/symptoms and documented
history, patterns of brain functioning, behavioral observations, collateral information, or
exaggerated psychological dysfunction, as evidenced by a scale such as the MMPI-2-RF
(Slick et al., 2010). For the purpose of the current study, patients who met criteria for
Definite, Probable, and Possible Malingering of Neurocognitive Dysfunction defined by
Slick et al. (2010) were included in the Poor Effort group for analysis.
The current study used the reviewed neurocognitive profiles to postulate selfreported memory impairment, employing the Memory Complaints Inventory (MCI).
Taking into consideration the severity of Alzheimer’s Disease, consisting of significant
cognitive deficits, anosognosia, and functional impairment, it was hypothesized that
individuals in the Alzheimer’s Disease sample group would produce an MCI profile
consisting of the least amount of memory complaints in relation to the subgroups being
analyzed in this study. With respect to the severity and variations of Vascular Dementia,
it was hypothesized that individuals in the Vascular Dementia sample group would
produce an MCI profile consisting of more reported memory complaints than those with
Alzheimer’s Disease, but fewer memory complaints than those diagnosed with Mild
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Cognitive Impairment, Pseudodementia, or those found to display poor effort. Because of
the variations in etiology and severity of Mild Cognitive Impairment, in addition to the
high comorbidity of Depression, it was postulated individuals in the Mild Cognitive
Impairment sample group would produce an MCI profile consisting of more reported
memory complaints than those with Alzheimer’s Disease and Vascular Dementia, but
fewer memory complaints than those diagnosed with Pseudodementia or found to display
poor effort. Finally, it was proposed that the individuals in the Pseudodementia or
Depression-Related Cognitive Impairment sample group would produce an MCI profile
consisting of the most reported memory complaints compared to those classified in the
Alzheimer’s Disease, Vascular Dementia, or Mild Cognitive Impairment diagnostic
categories. Although Pseudodementia was predicted to produce the greatest number of
overall memory complaints with respect to the dementia subgroups, the authors proposed
that the Poor Effort subgroup would produce the greatest overall memory complaint
profile while simultaneously producing the highest number of memory complaints on the
imbedded Implausible memory scale of the MCI. To clarify, the current study
hypothesized an inverse relationship of self-reported memory complaints utilizing the
MCI and the severity of dementia diagnosis. Further, due to the literature review, the
researchers postulated that a comorbidity of depression accompanying the primary
dementia diagnosis would have an impact on self-reported memory complaints.
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METHODS

Participants
Participants were selected from the archival database at CoxHealth Hospital
Neuropsychology Services in the Midwest. Individuals presented to the outpatient clinic
for various concerns, including memory complaints, attentional difficulties, interpersonal
and occupational conflicts, and neurology referrals. Protected Health Information release
forms (Appendix A) were signed at the time of their initial interviews, endorsing their
results may be used in research studies. Further, this study was approved by the
Institutional Review Board at Missouri State University, clarifying this research does not
permit any harm to the subjects involved (see Appendix B). Those selected for inclusion
in this project were all adults assessed at the outpatient Neuropsychology clinic who were
administered the Memory Complaints Inventory and an individualized
neuropsychological test battery for diagnostic purposes. Data gathered included the
individual’s age, gender, ethnicity, handedness, education level, Memory Complaints
Inventory results, and diagnoses.
Two hundred forty-four (n = 244) total participants were determined as meeting
inclusion criteria for the current study after data screening analyses. The average age was
63.6 years (SD = 13.67; 25 – 89 years of age) and consisted of 39.75% males (n = 97)
and 60.25% females (n = 147). Ethnicity of the sample was 98.36% (n = 240) White,
0.41% (n = 1) Mexican-American, 0.82% (n = 2) Native American, and 0.41% (n = 1)
West Indian. All other ethnicities were not represented in this study due to the limited
sample provided in the archival database from the Midwestern hospital in which data
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were collected. Additionally, 90.98% (n = 222) of the sample was right-handed, meaning
9.02% (n = 22) of the sample was left-handed. Table 1 depicts the complete
demographics of the sample for the study.

Table 1
Sample Demographics
Alzheimer’s
Disease

Primary Diagnostic Category
Mild
Vascular
PseudoCognitive
Dementia
dementia
Impairment
33
88
53
75.94 (8.01)
66.98 (8.78) 57.85 (12.77)

Poor Effort

Total n
21
49
Age M (SD)
77.00 (5.61)
49.69 (11.62)
Gender
Male
9
14
45
11
18
Female
12
19
43
42
31
Self-Identified Ethnicity
White
21
31
88
51
49
Mexican American
---1
-Native American
-1
-1
-West Indian
-1
---Education
7-11 Years
4
6
10
10
9
High School Graduate 12
20
26
21
17
1 Year College
1
2
11
4
4
2 Years College
1
1
7
6
6
3 Years College
-1
1
2
5
College Degree
2
1
13
7
7
Master’s Degree
1
1
15
2
1
Post Master’s Work
--3
1
-Doctoral Degree
-1
2
--Handedness
Right
12
33
80
49
43
Left
4
-8
4
6
Note: Ethnicity was self-identified; Education was separated by categories imbedded in the Memory
Complaints Inventory

Materials
The Memory Complaints Inventory (Green, 2004) was embedded in each
individual’s neuropsychological assessment battery conducted in the outpatient clinic. It
was designed to measure memory complaints by categorizing the complaints into nine
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separate scales, consisting of General Memory Problems (GMP), Numerical Information
Processing and Memory Problems (NIP), Visual-Spatial Memory Problems (VSMP),
Verbal Memory Problems (VMP), Pain Interferes with Memory (PIM), Memory
Interferes with Work (MIW), Impairment of Remote Memory (IRM), Amnesia for
Complex Behavior (ACB), and Amnesia for Antisocial Behavior (AAB). Participants are
asked how true a statement is for them within the last month. The Memory Complaints
Inventory is comprised of 58 Likert-type items on a zero- to four-point scale ranging
from “not at all true” to “extremely true.” The first seven scales make up the Plausible
memory items, indicating true memory impairment, while the last two scales, ACB and
AAB, present the Implausible memory complaints category which may indicate symptom
validity concerns when the Implausible scales are elevated. The MCI has high reliability
( = 0.93) for all nine scales, as well as high internal reliability, assessed by split-thirds
reliability standards. High scores on the first seven scales represent one’s subjective
memory complaints are greater than that of a normal population, while high scores on the
ACB and AAB scales suggest an exaggerated subjective memory experience.

Procedure
Data were collected over a two-year period in an outpatient Neuropsychology
Services Clinic. Every patient who presented to the outpatient clinic and complained of
memory complaints was administered the MCI as a part of their Neuropsychological
testing battery. The MCI was randomly administered throughout the course of the
assessment process.
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Data Screening
All data were screened for accuracy and missing data. Participants with more than
5% missing data (i.e., 2 or more items) were excluded, as Tabachnick and Fidell (2012)
have suggested that 5% or less of missing data may be safely filled in with minimal
effects on hypothesis testing. In this particular dataset, there was no missing data, as all
participants were required to complete every question to finish the MCI in their
neuropsychological testing batteries. The final sample sizes, as shown in Table 1
remained sufficient for analyses described below. Of note, however, is the Alzheimer’s
Disease group, of which failed to meet the central limit theorem necessary for powerful
analyses, thus, the results of the Alzheimer’s Disease group analysis should be interpreted
with caution, as it may represent an overestimation or underestimation of scores that
would be seen with a larger sample size.
Next, each dataset was examined for multivariate outliers using Mahalanobis
distance (Tabachnick & Fidell, 2012). As described in Tabachnick and Fidell (2012),
Mahalanobis values were calculated for each participant based on their answer choice
patterns for each of the fifty-eight questions. These D values are compared to a χ2(58)
p<.001 = 32.91, and observations with D values greater than this score were counted as
outliers. For this dataset, there were four outliers that met the Mahalanobis distance
criteria and were excluded from this analysis. This analysis is similar to using a z-score
criterion of three standard deviations away from the mean.
Finally, the dataset was screened for multivariate assumptions of additivity,
linearity, normality, homogeneity, and homoscedasticity. There were high correlations
between the General Memory Problems (GMP) subscale and the Plausible imbedded
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validity scale (r = .93), as well as the GMP subscale and the Overall score (r = .92) on the
MCI. Additionally, the Plausible scale was highly correlated with the Verbal Memory
Problems (VMP) subscale (r = .92) and the Memory Interferes with Work (MIW)
subscale (r = .91). While high correlations between subscales on a measure typically
indicate poor measure structure and collapsible subscales, in this case, we would
anticipate high correlations among the GMP, VMP, and MIW subscales with the
Plausible scale and Overall score due to the impact these difficulties have on individuals
in everyday life and the way in which the MCI was created. For example, General
Memory Problems should weigh heavily into the Plausible validity scale and Overall
score, meaning the General Memory Problems reported represent genuine impairment
and reflect overarching self-identified impairment derived from the Overall total score.
Further, the Amnesia for Complex Behavior (ACB) subscale was highly correlated with
the Implausible imbedded validity scale (r = .94) and the Overall total score (r = .91).
Again, these correlations are anticipated since the Implausible validity scale was derived
from scores on the ACB and AAB (Amnesia for Antisocial Behavior), which ultimately
impact Overall total score by self-identified impairment. Finally, large correlations were
observed on the Overall total score compared with both the Plausible (r = .98) and
Implausible (r = .93) imbedded validity measures, commensurate with expectation
considering the development of the scale referenced previously.
Data met the assumption for linearity, and data were only slightly kurtotic
meeting the assumption for normality. Additionally, the assumptions of homogeneity and
homoscedasticity were met for the overall dataset.
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Data Analysis
One-way between-subjects analysis of variance (ANOVA) statistics were
conducted to compare the effect of dementia diagnosis on self-reported memory
complaints for each subscale of the MCI. Thus, twelve one-way ANOVAs were utilized
to encompass all subscales of the MCI, including overall score for memory complaints
and the plausible and implausible validity scales imbedded into the MCI. Pairwise
independent t-tests were conducted to compare the distinct differences between dementia
subgroups with Bonferroni corrections to account for the inflation of type I error.
Cohen’s d effect size analyses were run for every comparison to provide additional
evidentiary value and to provide a practical source of significance in addition to the
traditional view of statistical significance of p-values. Further, a 3 (diagnostic category:
Vascular Dementia vs. Mild Cognitive Impairment vs. Poor Effort) X 2 (presence
secondary diagnosis of depression: secondary depression vs. no secondary depression)
between-subjects ANOVA was conducted to determine if a secondary diagnosis of
depression had an interaction with participants’ overall score on the MCI, as postulated
by the researchers. The Alzheimer’s Disease diagnostic condition was omitted from this
two-factor ANOVA due to the limited number of Alzheimer’s participants concurringly
diagnosed with depression in this sample (n = 7), resulting in low statistical power for
this analysis, thus not reasonable to evaluate. Further, the Pseudodementia group was
omitted from the two-factor ANOVA due to depression as the primary diagnosis rather
than the secondary diagnosis, as a result of the neuropsychological profile associated with
Pseudodementia.
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RESULTS

Data from adults presenting to a neuropsychology outpatient clinic were analyzed
to determine differences in memory complaint profiles on the Memory Complaints
Inventory (MCI). Five subgroups of patients were derived from their primary diagnosis in
the archives, consisting of Alzheimer’s Disease patients, Vascular Dementia patients,
Mild Cognitive Impairment patients, Pseudodementia patients, and patients who
presented to the clinic for memory complaints that were considered to produce a profile
consistent with poor effort on their individualized neuropsychological testing battery. The
researchers hypothesized an inverse relationship of memory complaints and diagnostic
severity of dementia. Specifically, it was postulated the Alzheimer’s Disease patients
would produce the least amount of memory complaints based on the literature of the
typical neurocognitive profile. It was predicted Vascular Dementia patients would present
with the second lowest number of overall memory complaints on the MCI. The Mild
Cognitive Impairment group was hypothesized to report a larger amount of memory
complaints on the MCI relative to Vascular Dementia patients, yet a lower number of
memory complaints than the Pseudodementia group. Finally, the Pseudodementia
patients were predicted to encompass the greatest amount of memory complaints relative
to the dementia subgroups; however, the Poor Effort subset of patients were hypothesized
to surpass all dementia diagnostic categories and produce the greatest number of overall
memory complaints on the MCI while also elevating the imbedded validity scales.
The hypotheses for the study were tested using one-way between-subjects
ANOVAs to compare differences in scores between primary diagnostic groups on all nine
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subscales of the MCI, the overall number of memory complaints, and the Plausible and
Implausible imbedded validity scales. The results of the 12 one-way ANOVAs can be
seen in Table 2, below. Welch corrections were utilized for the ANOVAs in which
Levene’s test of homogeneity was significant. There was a significant effect of primary
dementia diagnosis on overall memory complaints F(4, 91.11) = 41.02, p < .001, η2= .74.
Post hoc independent t-tests with a Bonferroni correction were used to find differences in
overall memory scores between each primary diagnosis. For overall memory scores,
Alzheimer’s Disease significantly differed from the Pseudodementia group (p = .002, d =
0.93) and the Poor Effort group (p < .001, d = 2.58) with large effect sizes for both
significant differences. Pseudodementia was significantly different from the Poor Effort
group (p < .001, d = 1.27) with regard to overall memory complaints. The Mild Cognitive
Impairment group significantly differed in overall memory complaints from the Poor
Effort group (p < .001, d = 1.86), and the Poor Effort group significantly differed from
the Vascular Dementia group (p < .001, d = 2.03). All post hoc comparisons can be found
in Appendix C. The data obtained followed the trend predicted in that Alzheimer’s
Disease patients reported the least amount of overall memory complaints on the MCI,
while those in the Poor Effort group reported the greatest amount of overall memory
complaints, in a step-wise progression with a decrease of severity in diagnosis.
Primary dementia diagnosis also resulted in significant differences on the
Plausible memory scale F(4, 90.39) = 41.78, p < .001, η2= .75, which represents one of
the imbedded validity measures of the MCI and alludes that patients are being honest in
the memory complaints they are reporting. Post hoc independent t-tests with a Bonferroni
correction were utilized to examine the differences in Plausible memory subscale scores

28

between each primary diagnosis. Significant results were found when comparing
Alzheimer’s Disease to Pseudodementia (p = .002, d = 0.94), Alzheimer’s Disease to
Poor Effort (p < .001, d = 2.65), Pseudodementia to Poor Effort (p < .001, d = 1.27),
Pseudodementia to Vascular Dementia (p = .05, d = 0.58), Mild Cognitive Impairment to
Poor Effort (p < .001, d = 1.80), and Poor Effort to Vascular Dementia (p < .001, d =
2.08). All significant post hoc comparisons with the Plausible memory subscale resulted
in large effect sizes with the exception of the comparison of Pseudodementia to Vascular
Dementia, of which resulted in a medium effect.
Finally, primary dementia diagnosis had significant effects on the Implausible
memory scale of the MCI F(4, 92.31) = 23.43, p < .001, η2= .64, which represents the
second imbedded validity scale and indicates patients are likely not being honest in their
memory complaint presentation. Again, post hoc independent t-tests with a Bonferroni
correction were conducted to examine the differences in Implausible memory subscale
scores between each primary dementia diagnosis. Significant results were found when
comparing Alzheimer’s Disease to Pseudodementia (p = .03, d = 0.80), Alzheimer’s
Disease to Poor Effort (p < .001, d = 1.85), Pseudodementia to Poor Effort (p < .001, d =
1.04), Mild Cognitive Impairment to Poor Effort (p < .001, d = 1.57), and Poor Effort to
Vascular Dementia (p < .001, d = 1.50). All significant post hoc comparisons with the
Plausible memory subscale resulted in large effect sizes.
A general trend is seen in most of the nine subscales in Table 2 in which
Alzheimer’s Disease patients reported the least amount of memory complaints, while the
Poor Effort group reported the greatest amount of memory complaints.
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Table 2
Primary Diagnosis Effects on Memory Complaints Inventory Subscales
Mild
Alzheimer’
Vascular
PseudoCognitive
s Disease M
Dementia M
dementia M
Impairment M
(SD)
(SD)
(SD)
(SD)
n

30

Poor Effort
M (SD)

F(df,df) = F

p

Ƞ2

21

33

88

53

49

GMP

4.08 (3.14)

6.06 (4.65)

6.70 (4.78)

8.87 (5.68)

15.65 (5.33)

F(4, 90.06) = 36.08

<.001*

.69*

NIP

6.00 (3.52)

7.21 (4.26)

7.67 (4.72)

9.35 (5.67)

15.31 (4.87)

F(1, 239) = 692.20

<.001*

.74*

VSMP

4.10 (3.03)

4.30 (3.79)

4.80 (3.90)

5.30 (4.14)

9.71 (3.97)

F(1, 239) = 409.10

<.001*

.63*

VMP

4.62 (2.52)

6.27 (4.35)

7.66 (4.35)

9.68 (5.09)

13.73 (3.55)

F(4, 91.21) = 41.77

<.001*

.76*

PIM

1.14 (1.85)

1.12 (1.62)

2.17 (2.76)

3.06 (3.46)

5.92 (3.98)

F(4, 91.88) = 16.35

<.001*

.39*

MIW

3.57 (2.99)

6.15 (4.21)

6.24 (5.55)

8.49 (6.14)

13.96 (4.48)

F(4, 93.33) = 36.03

<.001*

.64*

IRM

3.19 (2.77)

5.42 (3.90)

5.34 (4.46)

7.09 (6.22)

11.45 (6.76)

F(4, 92.03) = 13.71

<.001*

.56*

ACB

5.48 (3.82)

7.06 (5.59)

6.99 (6.63)

10.49 (7.61)

18.47 (8.33)

F(4, 93) = 22.93

<.001*

.61*

AAB

0.90 (1.22)

1.27 (2.07)

1.31 (2.23)

1.34 (2.02)

3.55 (3.32)

F(4, 92.71) = 5.97

<.001*

.29*

Plaus

3.91 (2.34)

5.19 (3.40)

5.87 (3.68)

7.46 (4.20)

12.38 (3.49)

F(4, 90.39) = 41.78

<.001*

.75*

Implaus

3.19 (2.23)

4.59 (3.37)

4.55 (3.77)

6.31 (4.37)

11.16 (4.93)

F(4, 92.31) = 23.43

<.001*

.64*

Overall

3.67 (2.16)

4.99 (3.23)

5.43 (3.50)

7.07 (4.10)

11.97 (3.56)

F(4, 91.11) = 41.02

<.001*

.74*

Note: GMP = General Memory Problems; NIP = Numerical Information Processing; VSMP = Visual-Spatial Memory Problems; VMP
= Verbal Memory Problems; PIM = Pain Interferes with Memory; MIW = Memory Interferes with Work; IRM = Impairment of Remote
Memory; ACB = Amnesia for Complex Behavior; AAB = Amnesia for Antisocial Behavior; Plaus = Plausible Memory Complaints;
Implaus = Implausible Memory Complaints; * indicates significance

Additionally, a 3 (diagnostic category: Vascular Dementia vs. Mild Cognitive
Impairment vs. Poor Effort) X 2 (presence secondary diagnosis of depression: secondary
depression vs. no secondary depression) between-subjects ANOVA was conducted to
determine if a secondary diagnosis of depression had an interaction with participants’
overall score on the MCI. The Alzheimer’s Disease patients were omitted from this
analysis due to the small sample size who were concurrently diagnosed with depression.
Table 3 below displays the results of the analysis.

Table 3
Interaction of Secondary Diagnosis of Depression on Overall Memory
Complaints
F(df, df) = F
p
Overall
F(1, 164) = 657.14 <.001*

Ƞ2
.80*

Primary Diagnosis

F(2, 164) = 63.89

<.001*

.44*

Secondary Diagnosis of Depression

F(1, 164) = 0.85

.36

.01

Primary and Secondary Interaction
Note: * denotes significance

F(2, 164) = 0.15

.86

.002

The overall 3 X 2 between-subjects ANOVA was significant F(1, 164) = 657.14,
p < .001, η2= .80, with a large effect. The data suggests there is no interaction between a
secondary diagnosis of depression and primary diagnosis of dementia on overall memory
complaints reported on the MCI F(2, 164) = 0.15, p < .36, η2= .01; however, the analysis
indicates a primary diagnosis of dementia is significant on overall memory complaints
F(2, 164) = 63.89, p < .001, η2= .44, with a large effect, which is explained in the primary
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results, above. Therefore, post hoc analyses were not conducted due to non-significant
results of a secondary diagnosis of depression.
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DISCUSSION

As the field of Neuropsychology has progressed, our research and understanding
of the neurocognitive disorders has also progressed. Yet, there is often unclear distinction
between the neurodegenerative disorders and their objective presentations in a general
practice setting. Many researchers have endeavored to make distinctions in behavioral
presentations of dementia and objective test data that facilitate general medical practice
and comprise our neuropsychological profiles; however, the use of short questionnaires
and scores on the commonly used Mini Mental Status Exam (MMSE), Saint Louis
University Mental Status (SLUMS) exam, or the Montreal Cognitive Assessment
(MOCA) rarely provide insight into diagnostic specificity of dementia. The lack of
available specificity in generalized medical practice assessments may often result in poor
treatment modalities since the differentiation of diagnosis has a large impact on prognosis
and interpersonal relationships. This study highlights the Memory Complaints Inventory
(MCI) as a tool to be utilized in general practice to provide insight into diagnostic
specificity of dementia while also differentiating from those who are misrepresenting
themselves and offering poor effort for a multitude of reasons.
Based on the review of the literature, the researchers hypothesized an inverse
relationship between diagnostic severity of dementia and overall scores on the MCI,
suggesting a pattern in which Alzheimer’s patients would report the fewest memory
complaints due to the association of anosognosia (Clare et al., 2004; Ecklund-Johnson &
Torres, 2005; Lehrner et al., 2015). Vascular Dementia patients were predicted to report
more overall memory complaints than Alzheimer’s patients, yet fewer complaints than
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individuals diagnosed with Mild Cognitive Impairment, Pseudodementia, or those
meeting the requirements for Poor Effort. The researchers also proposed Mild Cognitive
Impairment patients would produce a profile of memory complaints greater than those
with Vascular Dementia and less than those with Pseudodementia or Poor Effort; while,
Pseudodementia patients were to represent the greatest number of memory complaints in
the dementia category. Poor Effort patients were postulated to produce the greatest
number of memory complaints overall and to significantly deviate in responses on the
Implausible imbedded validity scale. Finally, patients of whom received a secondary
diagnosis of depression were ascertained to produce significantly different results on the
Overall scores of the MCI.
Significant results were found on all one-way between-subjects ANOVAs, as seen
in Table 2, which supports the idea that individuals of different subgroups of dementia
produce statistically different and practically different profiles with regard to their selfreported memory complaints. Although the predicted trend was met, there were not
significant differences between all subgroups, suggesting the differences in self-reported
memory complaints may not be as substantial as the researchers first predicted. It appears
the greatest difference can be found between the primary dementia diagnoses and the
Poor Effort group with regard to overall memory complaints, as the Poor Effort group
was found to significantly differ from all dementia subgroups with large effect sizes. In
addition, the Poor Effort subgroup significantly deviated from all other dementia
subgroups on the Implausible validity scale of the MCI. These findings further support
the utilization of the Memory Complaints Inventory in its intended use as a symptom
validity scale (Green, 2004), even in populations with neurodegenerative disorders.

34

Additionally, since a plethora of authors suggest an association of depression with
all of the dementia subgroups being tested in the current study (Park et al., 2007; Payne et
al., 1998; Ravdin & Katzen, 2013; Starkstein et al., 2005), a two-way between-subjects
ANOVA was conducted to test the theory that a comorbid diagnosis of depression would
significantly impact overall self-reported memory complaints. The results of this analysis
were nonsignificant and may indicate that although depression is often a concurring
factor among the dementia populations, it may not be impacting the perception of
patients’ memory more than the genuine neurological impairment patients experience as
a result of a neurodegenerative disorder. This finding is particularly important since the
Pseudodementia subgroup produced a memory complaints profile which consisted of a
higher number of overall memory complaints than all other dementia subgroups
(Alzheimer’s Disease, Vascular Dementia, and Mild Cognitive Impairment), meaning
depression as a single occurring construct substantially impacts one’s view of their
overall memory functioning; though, concurrently with a primary diagnosis of dementia,
the effects of depression dissipate.
This study was conducted on adult outpatients from a Midwestern hospital in
which 98% of the sample was white. It would be advantageous to conduct the same
research utilizing a more diverse sample from across the United States to replicate the
results found in this study. Further, the Alzheimer’s Disease group was comprised of only
21 patients, thus under-powering the results of this specific subgroup. A dataset
containing more Alzheimer’s Disease patients would add to the robustness of the results
found in the current study. Consistent with the Alzheimer’s sample limitation, the sample
of comorbidity of depression with Alzheimer’s Disease was too small to include in the
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two-way analysis, thus leaving the question of depression impacting overall memory
complaints in Alzheimer’s patients unanswered. Overall, future research differentiating
self-reported memory complaints in dementia populations should consist of larger sample
sizes, including those who obtained a secondary diagnosis of depression.
Future research with the Memory Complaints Inventory would be advantageous
in comparison with performance validity tests (PVTs), as well as performance on
objective memory measures, such as the California Verbal Learning Test (CVLT), the
Hopkins Verbal Learning Test (HVLT), and the Repeatable Battery for the Assessment
of Neuropsychological Status (RBANS) to investigate differences in subjective memory
complaints and objective memory performance, rather than diagnostic outcome, which
was the focus of the current study.
With the addition of further support of the results found in this study with a
variety of dementia patient samples, accurate genuine memory impairment profiles can
be developed and utilized in general practice settings to facilitate more effective
treatment planning and prognostic descriptions given to patients and loved ones. The
utilization of the MCI in general practice settings surpasses other measures of selfreported memory complaints due to its added value of the imbedded symptom validity
scales, indicating its complementary value in quick assessment scenarios.
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APPENDIX C

Post Hoc Comparisons
Appendix C-1
Post Hoc Comparison of Alzheimer’s Disease and
Pseudodementia
DV
Group 1
Group 2
p
d
GMP
AD
Pseudo
.002*
0.95***
NIP
AD
Pseudo
.08
0.65**
VSMP
AD
Pseudo
1.00
0.31*
VMP
AD
Pseudo
<.001*
1.12***
PIM
AD
Pseudo
.15
0.62**
MIW
AD
Pseudo
.003*
0.90***
IRM
AD
Pseudo
.04*
0.71**
ACB
AD
Pseudo
.05*
0.74**
AAB
AD
Pseudo
1.00
0.24*
Plausible
AD
Pseudo
.002*
0.94***
Implausible AD
Pseudo
.03*
0.80***
Overall
AD
Pseudo
.002*
0.93***
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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Appendix C-2
Post Hoc Comparison of Alzheimer’s Disease and Mild Cognitive
Impairment
DV
Group 1
Group 2
p
d
GMP
AD
Mild CI
.29
0.59**
NIP
AD
Mild CI
1.00
0.37*
VSMP
AD
Mild CI
1.00
0.19
VMP
AD
Mild CI
.04*
0.75**
PIM
AD
Mild CI
1.00
0.39
MIW
AD
Mild CI
.34
0.52**
IRM
AD
Mild CI
.93
0.51**
ACB
AD
Mild CI
1.00
0.24*
AAB
AD
Mild CI
1.00
0.20*
Plausible
AD
Mild CI
.27
0.56**
Implausible AD
Mild CI
1.00
0.38*
Overall
AD
Mild CI
.41
0.53**
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
Appendix C-3
Post Hoc Comparison of Alzheimer’s Disease and Poor Effort
DV
Group 1
Group 2
p
d
GMP
AD
PE
<.001*
2.42***
NIP
AD
PE
<.001*
2.06***
VSMP
AD
PE
<.001*
1.51***
VMP
AD
PE
<.001*
2.78***
PIM
AD
PE
<.001*
1.37***
MIW
AD
PE
<.001*
2.54***
IRM
AD
PE
<.001*
1.41***
ACB
AD
PE
<.001*
1.78***
AAB
AD
PE
<.001*
0.92***
Plausible
AD
PE
<.001*
2.65***
Implausible AD
PE
<.001*
1.85***
Overall
AD
PE
<.001*
2.58***
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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Appendix C-4
Post Hoc Comparison of Alzheimer’s Disease and Vascular
Dementia
DV
Group 1
Group 2
p
d
GMP
AD
VD
1.00
0.49*
NIP
AD
VD
1.00
0.30*
VSMP
AD
VD
1.00
0.06
VMP
AD
VD
1.00
0.44*
PIM
AD
VD
1.00
0.01
MIW
AD
VD
.74
0.68**
IRM
AD
VD
1.00
0.64**
ACB
AD
VD
1.00
0.32*
AAB
AD
VD
1.00
0.21*
Plausible
AD
VD
1.00
0.42*
Implausible AD
VD
1.00
0.47*
Overall
AD
VD
1.00
0.46*
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
Appendix C-5
Post Hoc Comparison of Pseudodementia and Mild Cognitive
Impairment
DV
Group 1
Group 2
p
d
GMP
Pseudo
Mild CI
.13
0.42*
NIP
Pseudo
Mild CI
.46
0.33*
VSMP
Pseudo
Mild CI
1.00
0.13
VMP
Pseudo
Mild CI
.07
0.44*
PIM
Pseudo
Mild CI
.94
0.29*
MIW
Pseudo
Mild CI
.13
0.39*
IRM
Pseudo
Mild CI
.56
0.34*
ACB
Pseudo
Mild CI
.04*
0.50**
AAB
Pseudo
Mild CI
1.00
0.01
Plausible
Pseudo
Mild CI
.13
0.41*
Implausible Pseudo
Mild CI
.12
0.44*
Overall
Pseudo
Mild CI
.08
0.44*
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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Appendix C-6
Post Hoc Comparison of Pseudodementia and Poor Effort
DV
Group 1
Group 2
p
d
GMP
Pseudo
PE
<.001*
1.23***
NIP
Pseudo
PE
<.001*
1.12***
VSMP
Pseudo
PE
<.001*
1.09***
VMP
Pseudo
PE
<.001*
0.92***
PIM
Pseudo
PE
<.001*
0.77**
MIW
Pseudo
PE
<.001*
1.01***
IRM
Pseudo
PE
<.001*
0.67**
ACB
Pseudo
PE
<.001*
1.00***
AAB
Pseudo
PE
<.001*
0.81***
Plausible
Pseudo
PE
<.001*
1.27***
Implausible Pseudo
PE
<.001*
1.04***
Overall
Pseudo
PE
<.001*
1.27***
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes

Appendix C-7
Post Hoc Comparison of Pseudodementia and Poor Vascular
Dementia
DV
Group 1
Group 2
p
d
GMP
Pseudo
VD
.12
0.53**
NIP
Pseudo
VD
.46
0.42*
VSMP
Pseudo
VD
1.00
0.25*
VMP
Pseudo
VD
.004*
0.71**
PIM
Pseudo
VD
.04*
0.67**
MIW
Pseudo
VD
.42
0.43*
IRM
Pseudo
VD
1.00
0.31*
ACB
Pseudo
VD
.27
0.50**
AAB
Pseudo
VD
1.00
0.03
Plausible
Pseudo
VD
.05*
0.58**
Implausible Pseudo
VD
.55
0.43*
Overall
Pseudo
VD
.08
0.55**
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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Appendix C-8
Post Hoc Comparison of Mild Cognitive Impairment and Poor
Effort
DV
Group 1
Group 2
p
d
GMP
Mild CI
PE
<.001*
1.8***
NIP
Mild CI
PE
<.001*
1.6***
VSMP
Mild CI
PE
<.001*
1.25***
VMP
Mild CI
PE
<.001*
1.49***
PIM
Mild CI
PE
<.001*
1.16***
MIW
Mild CI
PE
<.001*
1.49***
IRM
Mild CI
PE
<.001*
1.13***
ACB
Mild CI
PE
<.001*
1.58***
AAB
Mild CI
PE
<.001*
0.84***
Plausible
Mild CI
PE
<.001*
1.80***
Implausible Mild CI
PE
<.001*
1.57***
Overall
Mild CI
PE
<.001*
1.86***
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
Appendix C-9
Post Hoc Comparison of Mild Cognitive Impairment and
Vascular Dementia
DV
Group 1
Group 2
p
d
GMP
Mild CI
VD
1.00
0.13
NIP
Mild CI
VD
1.00
0.10
VSMP
Mild CI
VD
1.00
0.13
VMP
Mild CI
VD
1.00
0.32*
PIM
Mild CI
VD
.92
0.42*
MIW
Mild CI
VD
1.00
0.02
IRM
Mild CI
VD
1.00
0.02
ACB
Mild CI
VD
1.00
0.01
AAB
Mild CI
VD
1.00
0.02
Plausible
Mild CI
VD
1.00
0.19
Implausible Mild CI
VD
1.00
0.01
Overall
Mild CI
VD
1.00
0.13
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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Appendix C-10
Post Hoc Comparison of Poor Effort and Vascular Dementia
DV
Group 1
Group 2
p
d
GMP
PE
VD
<.001*
1.90***
NIP
PE
VD
<.001*
1.78***
VSMP
PE
VD
<.001*
1.39***
VMP
PE
VD
<.001*
1.92***
PIM
PE
VD
<.001*
1.48***
MIW
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VD
<.001*
1.79***
IRM
PE
VD
<.001*
1.04***
ACB
PE
VD
<.001*
1.55***
AAB
PE
VD
<.001*
0.79**
Plausible
PE
VD
<.001*
2.08***
Implausible PE
VD
<.001*
1.50***
Overall
PE
VD
<.001*
2.03***
Note: * indicates statistical significance for p-values; * indicates
small effect sizes, ** indicates medium effect sizes, and ***
indicates large effect sizes
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